Form D — RAPT Therapeutics, Inc.
0001673772-25-000001 · filed 2025-01-03
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $149,984,200
- Total sold
- $149,984,200
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- RAPT Therapeutics, Inc.
- CIK
- 1673772
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 561 ECCLES AVENUE
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 489-9000
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Brian Wong · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Michael Giordano · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Mary Ann V. Gray · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Lori Lyons-Williams · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
William J. Rieflin · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Linda Kozick · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Wendye Robbins · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Rodney Young · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Dirk Brockstedt · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
William Ho · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.